Navigation Links
Chinese Distribution Contract Extended for an Additional 4 Years
Date:2/5/2010

FOUNTAIN HILLS, Ariz., Feb. 5 /PRNewswire-FirstCall/ -- Sunridge International (OTC Bulletin Board: SNDZ) announced today that they have extended the exclusive distribution agreement with Beijing Vision World Trading Co., Ltd. for an additional 4 years.

"I am very happy to sign this agreement," states G. Richard Smith, CEO of Sunridge International (www.sunridgeint.com). "We have worked closely with Beijing Vision World Trading Co., Ltd. (BV) over the last 3 1/2 years to complete the registration process for Pneumatic Trabeculoplasty, 'PNT' in China."

PNT is a two-minute, noninvasive, cost effective, alternative treatment for glaucoma and ocular hypertension, which was developed and patented by Ophthalmic International (www.oi-pnt.com), Sunridge Internationals wholly owned subsidiary.

"The registration process for a medical device and treatment is very strict in China.  It is a very long, expensive and tedious procedure," states Mr. Smith.  BV has worked tirelessly over the last 3 1/2 years at a tremendous financial cost to its company to compete this process.  They have performed several successful clinical trials at both private and state military hospitals as part of this effort.  With approval expected in the very near future, BV is now concentrating on its marketing efforts.  They have ordered and received delivery on 5 units with a substantial number of disposable rings, to be placed in 5 major hospitals in Beijing.  These hospitals will be used as models for the rest of the country.  They are currently negotiating with a number of companies to act as sub distributors to expand distribution throughout all of China.  They are attending different levels of Academy Conferences and Exhibitions as part of their "PNT" awareness program.  Doctors and distributor personal are being trained.  BV is doing everything possible to ensure the successful marketing of PNT in China.

Mr. Smith goes on to say, "that this is a significant event for OI.  China is a major market for us, with millions of Glaucoma patients.  The fact that a 'PNT' treatment lasts 3-4 months as a rule, with little or no side effects, makes it a very viable treatment for not only for the people of China, but for people everywhere.  We expect that this will prove to be a very profitable market for OI."

Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995.  Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, continued acceptance of the company's products, increased levels of competition for the company, new products and technological changes, the company's dependence on third-party suppliers, and other risks detailed from time to time in the company's periodic reports filed with the Securities and Exchange Commission.

CONTACT:  Jeff Smith of Sunridge International, +1-480-837-6165, info@sunridgeint.com

SOURCE Sunridge International

RELATED LINKS
http://www.sunridgeint.com/
http://www.oi-pnt.com/

'/>"/>

SOURCE Sunridge International
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Tainted Chinese Food Ingredients First Discovered in 2005
2. Chinese SFDA Grants Immtech Fast Track Status
3. Kibow Biotech Obtains Australian, Chinese and Indian Patents Protecting the Composition and Basic Technology Behind Its Oral Probiotic Formulation for Chronic Kidney Failure
4. Phytomedics Inc. Announces Publication of the Phase 2b Clinical Trial Results of an Extract of the Chinese Herbal Remedy Tripterygium wilfordii Hook F in Rheumatoid Arthritis
5. Biostar Pharmaceuticals, Inc. Receives the Chinese Military Drug Administration Clearance to Begin Clinical Trial for Zushima Analgesic Aerosol Spray
6. Chinese Food and Drug Administration Approves Gabexate Mesylate as Pharmaceutical Raw Material
7. NeoStem Acquires China Biopharmaceuticals Holdings, Inc.; Obtains Controlling Interest in Profitable Leading Chinese Pharmaceutical Company
8. Reportlinker Adds Chinese Markets for Respiratory Drugs
9. Reportlinker Adds Chinese Markets for Bladder Cancer Treatment Drugs
10. Tongjitang Chinese Medicines Acquires Guiyang Liquor Factory
11. Chinese State Food and Drug Administration Approves Company Facility for Producing Solid Dosage Perindopril
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... -- Research and Markets has announced the addition ... report to their offering. ... The World Market for Companion Diagnostics covers the world ... in the report includes the following: , ... by Region (N. America, EU, ROW), 2015-2020 , World ...
(Date:6/24/2016)... , Belgium , June ... MKT: VNRX), today announced the appointment of Dr. ... of Directors as a Non-Executive Director, effective June ... Company,s Audit, Compensation and Nominations and Governance Committees.  ... Dr. Futcher will provide independent expertise and strategic ...
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
Breaking Medicine Technology:
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/24/2016)... ... 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. ... the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has ... , Sickle Cell Disease (SCD) is a disorder of the red blood cells, which ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):